NCT00055302 - Arimidex in McCune Albright Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

August 31, 2015

Conditions

McCune-Albright Syndrome

Interventions

DRUG

Arimidex 1 mg

Arimidex (anastrozole) 1mg once daily by mouth

Trial Locations (7)

Research Site, Montpellier

Research Site, Paris

Research Site, Berlin

Research Site, Erlangen

Research Site, Osnabrück

Research Site, Torino

Research Site, London